Replies to post #549520 on $Stock*Shop*Charts*News*Option$

[dDT]

EW Edwards Lifesciences beats by $0.07, beats on revenue

Edwards Lifesciences (NYSE:EW): Q3 EPS of $0.80 beats by $0.07.
Revenue of $607.4M (+22.6% Y/Y) beats by $61.08M.
Shares +5.71% AH.